Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Más filtros












Base de datos
Intervalo de año de publicación
1.
Int J Mol Sci ; 25(11)2024 Jun 03.
Artículo en Inglés | MEDLINE | ID: mdl-38892344

RESUMEN

SARS-CoV-2 is a highly infectious virus responsible for the COVID-19 pandemic. Therefore, it is important to assess the risk of SARS-CoV-2 infection, especially in persistently positive patients. Rapid discrimination between infectious and non-infectious viruses aids in determining whether prevention, control, and treatment measures are necessary. For this purpose, a method was developed and utilized involving a pre-treatment with 50 µM of propidium monoazide (PMAxx, a DNA intercalant) combined with a digital droplet PCR (ddPCR). The ddPCR method was performed on 40 nasopharyngeal swabs (NPSs) both before and after treatment with PMAxx, revealing a reduction in the viral load at a mean of 0.9 Log copies/mL (SD ± 0.6 Log copies/mL). Furthermore, six samples were stratified based on the Ct values of SARS-CoV-2 RNA (Ct < 20, 20 < Ct < 30, Ct > 30) and analyzed to compare the results obtained via a ddPCR with viral isolation and a negative-chain PCR. Of the five samples found positive via a ddPCR after the PMAxx treatment, two of the samples showed the highest post-treatment SARS-CoV-2 loads. The virus was isolated in vitro from both samples and the negative strand chains were detected. In three NPS samples, SARS CoV-2 was present post-treatment at a low level; it was not isolated in vitro, and, when detected, the strand was negative. Our results indicate that the established method is useful for determining whether the SARS-CoV-2 within positive NPS samples is intact and capable of causing infection.


Asunto(s)
Azidas , COVID-19 , Nasofaringe , Propidio , SARS-CoV-2 , Carga Viral , Humanos , SARS-CoV-2/genética , SARS-CoV-2/aislamiento & purificación , Azidas/química , Propidio/análogos & derivados , Propidio/química , COVID-19/virología , Carga Viral/métodos , Nasofaringe/virología , ARN Viral/genética , ARN Viral/aislamiento & purificación , Prueba de Ácido Nucleico para COVID-19/métodos , Reacción en Cadena de la Polimerasa/métodos
2.
Emerg Infect Dis ; 30(1): 183-184, 2024 Jan.
Artículo en Inglés | MEDLINE | ID: mdl-37967518

RESUMEN

Since August 2023, outbreaks of dengue virus (DENV) infection have occurred in Italy. We report 2 autochthonous case-patients and their extended follow-up. Despite persistent DENV detected in blood by PCR, results for antigenomic DENV RNA were negative after day 5, suggesting that a 5-day isolation period is adequate to avoid secondary cases.


Asunto(s)
Virus del Dengue , Dengue , Humanos , Dengue/diagnóstico , Dengue/epidemiología , Virus del Dengue/genética , Ciudad de Roma , Italia/epidemiología , Reacción en Cadena de la Polimerasa , Brotes de Enfermedades
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA
...